| Financial Year |
March 31 2023 |
| Monetary Funds |
4,666,138,400.32 |
| Held-for-trading Financial Assets |
1,180,648,545.83 |
| Notes Receivable |
271,695,307.74 |
| Accounts Receivable |
12,447,038,284.39 |
| Advances to Suppliers |
336,190,044.97 |
| Other Receivables |
286,362,944.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,811,579,888.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
164,983,446.75 |
| Other Current Assets |
226,037,534.90 |
| Total Current Assets |
30,083,645,185.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
177,510,902.14 |
| Long-term Equity Investment |
-- |
| Investment Properties |
110,299,801.72 |
| Fixed Assetes |
840,324,069.86 |
| Under-construction Projects |
5,600,307.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
106,007,307.58 |
| R&D expenses |
-- |
| Goodwill |
192,306,245.25 |
| Long-Term Deferred and Prepaid Expenses |
89,666,049.40 |
| Deferred Income Tax Assets |
1,204,032,613.47 |
| Other Non-Current Assets |
1,377,200,249.89 |
| Sub-Total of Non-Current Assets |
4,701,935,706.90 |
| Total Assets |
34,785,580,892.19 |
| Short-Term Loans |
345,990,836.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,142,871,078.62 |
| Accounts Payable |
11,882,940,738.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
716,554,823.55 |
| Taxes Payable |
94,061,344.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
463,411,505.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
133,124,786.60 |
| Other Current Liabilities |
1,374,064,905.60 |
| Sub-Total of Current Liabilities |
20,890,013,962.80 |
| Long-term Loans |
672,466,254.86 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,732,412.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
824,296,364.26 |
| Total Liabilities |
21,714,310,327.06 |
| Paid-In Capital(Or Share Stock) |
2,655,323,689.00 |
| Capital Surplus |
156,654,057.06 |
| Surplus Reserve |
1,360,431,738.20 |
| LESS:Treasury Stock |
249,834,424.52 |
| Undistributed Profits |
8,805,164,029.92 |
| Minority Stockholder's Interest |
311,253,934.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,760,016,630.91 |
| Owner's Equity（Stockholder's Equity） |
13,071,270,565.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
34,785,580,892.19 |
